Sarcopenia and frailty are highly prevalent conditions in older hospitalized patients, which
are associated with a myriad of adverse clinical outcomes. This paper, prepared by a …

Low muscle mass and function exert a substantial negative impact on quality of life, health
and ultimately survival, but their definition, identification and combination to define …

Objectives To present the local evidence and final recommendations of the Clinical Practice
Guidelines workgroup convened by the Chapter of Geriatricians and the Society for Geriatric …

The elderly people are characterized by multiple comorbidities, dementia, and are at risk of
develo** sarcopenia and frailty. Sarcopenia is defined by loss of muscle mass and muscle …

Screening of sarcopenia is critical for public health given its significant prevalence and
adverse outcomes. SARC-F is the most recommended tool for screening but has low …

Objective This review aimed to summarise the diagnostic accuracy of screening tools for
sarcopenia. Methods We conducted a systematic review along with a critical appraisal of …

Objectives This study aimed to assess and compare the frequency of positive scores using
unadjusted SARC-CalF with the scores derived from SARC-CalF after adjusting calf …

Sarcopenia is an age-related neuromuscular disease characterized by substantial muscle
atrophy, dynapenia and/or loss of physical function. Sarcopenia progression increases the …

Background Sarcopenia leads to functional disability, dependence in activities of daily living
(ADL), and is a key contributor to frailty. Reducing and breaking up sedentary time is …

Introduction Sarcopenia is a highly prevalent disease associated with adverse outcomes
such as falls, disability, and death. The current international consensuses agree that muscle …